Search results for "Farmaceutica"
showing 10 items of 582 documents
Alnus glutinosa (L.) Gaertn. and Alnus cordata (Loisel) Duby as new sources of safe cosmetic and pharmacological anti-melanogenic agents
2018
The genus Alnus (Betulaceae) comprises many species with a long history in traditional medicines. The crude extracts and isolated compounds from Alnus species exhibit a wide spectrum of in vitro and in vivo pharmacological activities (1). Phytochemical investigations revealed the presence of diarylheptanoids, a class of natural products typically found in Alnus genus with two aryl groups joined by a heptane chain in the main skeleton that have drawn attention due to their multiple biological properties and their therapeutic potential (2). A previous study reported that oregonin and other structurally analogous diarylheptanoids isolated from the bark of A. hirsuta showed inhibitory effects o…
MORINGA OLEIFERA (MAGNOLIOPHYTA) NELL’ORTO BOTANICO DI PALERMO
2011
Indagini fitochimiche sul galbano di Sicilia
2009
Una storia che viene da lontano
2017
La fitoterapia, cioè la cura delle malattie per mezzo dei vegetali, ha rappresentato il metodo utilizzato fin dall'antichità per alleviare le sofferenze e a volte curare o risolvere reali patologie mediante l’impiego di parti di piante fresche o essiccate o dei loro estratti naturali. Come si evince da questo breve excursus storico, in tutti i continenti, tutte le civiltà si sono dedicate, oltre che alla coltura di piante a scopo alimentare, alla ricerca di piante con proprietà terapeutiche. E’ straordinariamente interessante come, attraverso i millenni, l’insieme di queste nozioni si sia arricchito, e anche diversificato, senza essere mai interamente dimenticato.
CHEMICAL COMPOSITION OF THE ESSENTIAL OIL OF CLADANTHUS SCARIOSUS(ASTERACEAE) WILD GROWN IN MOROCCO
2014
Cladanthus Cass. [Syn. Ormenis (Cass.) Cass.] is a genus of the family Asteraceae, endemic to the Mediterranean region and related to the tribe Anthemideae (1). It comprises 15 species including C. scariosus (Ball) Oberpr. & Vogt [Bas. Santolina scariosa; Syn. Ormenis scariosa Litard. & Maire] from Morocco where is concentrates 1/3 of the species of the genus (2). Some of these are perennial, suffruticose and strongly aromatic plants. C. mixta (L.) Chev. is used in Morocco as chamomile and this is commonly called Moroccan chamomile. In the same country, C scariosus is fairly common in open places, on sandstone substrates (3) and is characterized by a strong aromatic character, this has moti…
Curcumin-Like Compounds as Neuroprotective Agents: Interactions with HSP60 and Amyloid Beta Peptide
2014
Alzheimer’s Disease (AD) represents a fundamental challenge for public health in the 21st century. Current AD therapies largely focus on symptomatic aspects of the clinical pathology, but they have yet to demonstrate any major impact on the disease progression [1]. The most important role of the research aimed at fighting the AD is the development of neuro-protective agents, able to interfere with the protein aggregation process whose clinical signature is represented by the plaques deposition. An important role in AD’s framework could be played by Heat shock proteins (HSPs), highly regulated proteins that mediate the proteins proper folding and promote recovery of their native conformation…
NOVEL ANTAGONISTS FOR AN Hsp60-BASED ANTICANCER CHAPERONOTHERAPY
2012
The Heat shock proteins (Hsps) are nowadays considered the most important cell chaperones, which result overexpressed in response to a number of cell stress stimuli.In tumor cells, when Hsp60 accumulates in the cytosol, without mitochondrial release, it exerts an anti-apoptotic effect, by inhibiting pro-caspase-3 (pC3) activation. In this context, our study aims to elucidate the structural details of the interaction between Hsp60 and pC3 and to design novel antagonists able to specifically block this interaction. The analysis of virtual screening results highlights the 4-(3-chloro-4-fluorophenylamino)- 6-[(1H-imidazol-4-yl-methyl)-3-carbonitrile-quinolines of type 1 and the N-{5-[1H-imidazo…
Optimization of a new lead promoting the readthrough of the nonsense mutations for CFTR rescue in human CF cells
2017
Optimization of a new lead promoting the readthrough of the nonsense mutations for CFTR rescue in human CF cells Laura Lentini, Raffaella Melfi, Sara Baldassano, Marco Tutone, Aldo Di Leonardo, Andrea Pace, Ivana Pibiri Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo Background and rationale Cystic Fibrosis patients with nonsense mutations in the CFTR gene have a more severe form of the disease. Nonsense mutations represent about 10% of the mutations that affect the CFTR gene and they are frequently associated to the classical F508 mutation (1). A potential treatment for this genetic alteration is to promote the translationa…
METHYLOMIC SIGNATURE AND MOLECULAR MODELLING TO BETTER UNDERSTAND AUTOPHAGY INDUCED BY PHYTOCHEMICAL IN CACO-2 CELLS
2019
The binomial “autophagy-cancer” is intricate and methylomic studies can help to understand it by changing point of view from a gene level to an -omic one. Recently, autophagy-modulating properties of several phytochemicals have attracted attention in anticancer research. We evaluated whether Indicaxanthin (IND), the peculiar known beneficial phytochemical of prickly pear, seasonally available in the southern Italy, could induce autophagy in Caco2 cells, and whether it results from an epigenomic modification and/or a direct molecular interaction. IND increased autophagy in Caco-2 cells; the methylomic signature, obtained by Reduced Representation Bisulfite Sequencing (15 million of clusters)…
Investigating the inhibition of FTSJ1 a tryptophan tRNA-specific 2’-O-methyltransferase by NV TRIDs, as a mechanism of readthrough in nonsense mutate…
2023
Abstract: Cystic Fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the CFTR gene, coding for the CFTR chloride channel. About 10% of the CFTR gene mutations are "stop" mutations, which generate a Premature Termination Codon (PTC), thus synthesizing a truncated CFTR protein. A way to bypass PTC relies on ribosome readthrough, which is the ri-bosome’s capacity to skip a PTC, thus generating a full-length protein. “TRIDs” are molecules exerting ribosome readthrough; for some, the mechanism of action is still under debate. We in-vestigate a possible mechanism of action (MOA) by which our recently synthesized TRIDs, namely NV848, NV914, and NV930, could exert their r…